Floatz logo

Calcarea Gluconica

Toxic Encephalopathy

Alliance for Clinical Trials in OncologySmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Toxic Encephalopathy cohort.

Asset / SponsorPhaseRating
Methotrexate
Radiation Therapy Oncology Group
Phase 2BB
Procarbazine
Radiation Therapy Oncology Group
Phase 2BB
Eribulin Monomethanesulfonate
Oncologia Medica dell'Ospedale Fatebenefratelli
Phase 4BB
Amitriptyline
Alliance for Clinical Trials in Oncology
Phase 3BB
Xaliplatin
Alliance for Clinical Trials in Oncology
Phase 3BB

View all 46 →

Same molecule, other indications

Calcarea Gluconica is also rated in:

peripheral neuropathyDormant
B
Indicative · Phase 3
61 / 100
View asset →
chemotherapy-induced toxicityDormant
B
Indicative · Phase 3
60 / 100
View asset →
osteoporosisDormant
B
Indicative · Phase 3
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →